US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 12, 2018 (8 years ago)

Zoledronic Acid Injection

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: OOS for unknown impurities.

What was recalled

Zoledronic Acid Injection, 5mg/100 mL (0.05 mg/mL) 100ml vial, Rx Only. Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. NDC 55111-688-52

Recalling firm
Dr. Reddy's Laboratories, Inc.
NDC code
55111-688-52
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0103-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Zoledronic recalls

See all
Class III · Low risk Terminated

Zoledronic Acid Injection 5 mg/100 mL

Reason Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.

Breckenridge Pharmaceutical, Inc NDC 51991-064-98 D-1063-2020
Class III · Low risk Terminated

Zoledronic Acid Injection

Reason Failed Impurities/Degradation Specifications: OOS for unknown impurities.

Dr. Reddy's Laboratories, Inc. NDC 43598-331-11 D-0104-2019
Class II · Moderate risk Terminated

Zoledronic Acid Injection

Reason Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial

Dr. Reddy's Laboratories, Inc. NDC 55111-688-52 D-0784-2016
Class II · Moderate risk Terminated

Zoledronic Acid active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-958-2015